99mTc-ciprofloxacin DRAXIMAGE.
DRAXIMAGE, under exclusive licence from BTG International Ltd, is developing a technetium-99m formulation of ciprofloxacin (INFECTON), as a radioimaging agent for the potential diagnosis of infection, including fever of unknown origin, osteomyelitis, wound infection, abdominal abscess, pneumonia, appendicitis and tuberculosis.
Tossing
Gudrun
G
Essex Pharma GmbH, Tannenstrasse 15a, 42653 Solingen, Germany. gudrun.tossing@essex.de
D000818:Animals; D002939:Ciprofloxacin / Q000031:analogs & derivatives* / Q000737:chemistry; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D015507:Drugs, Investigational / Q000737:chemistry; D006801:Humans; D007239:Infections / Q000175:diagnosis; D015609:Organotechnetium Compounds / Q000737:chemistry
D015507:Drugs, Investigational; D015609:Organotechnetium Compounds; C431804:Technetium Tc 99m ciprofloxacin; D002939:Ciprofloxacin